Target
Mu-type opioid receptor
Ligand
BDBM472105
Substrate
n/a
Meas. Tech.
Receptor Binding Assay
Ki
1.30±n/a nM
Citation
 Kuehnert, SKoenigs, RMKless, AWegert, ARatcliffe, PJostock, RKoch, TLinz, KSchroeder, WSchiene, KKonetzki, I 3-((hetero-)aryl)-alkyl-8-amino-2-oxo-l,3-diaza-spiro-[4.5]-decane derivatives US Patent  US10829480 Publication Date 11/10/2020 
Target
Name:
Mu-type opioid receptor
Synonyms:
M-OR-1 | MOP | MOR-1 | MOR1 | MUOR1 | Mu Opioid Receptor | Mu opiate receptor | OPIATE Mu | OPRM1 | OPRM_HUMAN | hMOP | mu-type opioid receptor isoform MOR-1
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
44789.51
Organism:
Homo sapiens (Human)
Description:
P35372
Residue:
400
Sequence:
MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP
  
Inhibitor
Name:
BDBM472105
Synonyms:
CIS-3-Benzy1-1-(cyclobutyl-methyl)-8-dimethylamino-8-phenyl-1,3- diazaspiro[4.5]decan-2-one | US10829480, Example SC_2096
Type:
Small organic molecule
Emp. Form.:
C28H37N3O
Mol. Mass.:
431.6129
SMILES:
CN(C)[C@]1(CC[C@]2(CN(Cc3ccccc3)C(=O)N2CC2CCC2)CC1)c1ccccc1 |r,wU:6.19,3.2,(-8.61,6.15,;-7.84,4.82,;-6.3,4.82,;-8.61,3.48,;-9.38,2.15,;-10.92,2.15,;-11.69,3.48,;-12.59,4.73,;-14.05,4.25,;-15.39,5.02,;-16.72,4.25,;-18.06,5.02,;-19.39,4.25,;-19.39,2.71,;-18.06,1.94,;-16.72,2.71,;-14.05,2.71,;-15.39,1.94,;-12.59,2.24,;-12.19,.75,;-13.28,-.34,;-14.82,-.34,;-14.82,-1.88,;-13.28,-1.88,;-10.92,4.82,;-9.38,4.82,;-7.84,2.15,;-8.61,.82,;-7.84,-.52,;-6.3,-.52,;-5.53,.82,;-6.3,2.15,)|
Structure:
Search PDB for entries with ligand similarity: